Soon Hyung Woo from Davis, CA, age 70

License Records

Soon Gee Woo

License #:

CC-0002393 - Active

Category:

Accountancy

Issued Date:

Sep 27, 2000

Type:

C.P.A. Certificate

Us Patents

Haloalkyl Containing Compounds As Cysteine Protease Inhibitors
view source
US Patent:

7547701, Jun 16, 2009
Filed:

Sep 17, 2004
Appl. No.:

10/943768
Inventors:

John O. Link - San Francisco CA, US
Craig J. Mossman - Campbell CA, US
Soon H. Woo - Palo Alto CA, US
Sheila M. Zipfel - Mountain View CA, US
Assignee:

Virobay, Inc. - Menlo Park CA
International Classification:

A61K 31/497
C07D 241/04
C07D 213/57
C07C 255/03
C07D 333/22
US Classification:

5142521, 514357, 514365, 5143961, 544393, 544400, 546330, 548204, 548205, 558404, 558414, 558431, 558434
Abstract:

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

Inhibitors Of Histone Deacetylase
view source
US Patent:

7595343, Sep 29, 2009
Filed:

Sep 12, 2002
Appl. No.:

10/242304
Inventors:

Daniel Delorme - St-Lazare, CA
Soon Hyung Woo - Foster City CA, US
Arkadii Vaisburg - Kirkland, CA
Oscar Moradei - Kirkland, CA
Silvana Leit - Kirkland, CA
Stephane Raeppel - Pierrefonds, CA
Sylvie Frechette - Lachine, CA
Giliane Bouchain - Beaconsfield, CA
Assignee:

MethylGene, Inc. - Quebec
International Classification:

C07C 211/51
C07D 239/24
C07D 239/72
C07D 403/12
C07D 403/14
C07D 413/14
C07D 417/14
C07D 409/12
C07D 405/12
A61K 31/505
A61K 31/506
A61K 31/53
A61K 31/136
A61K 31/166
A61P 35/00
US Classification:

514617, 564155, 564161, 549 59, 549 68, 549362, 549434, 544 50, 544196, 544113, 544353, 544358, 544264, 544283, 544 49, 544 90, 544105, 544180, 544359, 546139, 5462681, 546452, 548143, 548146, 548152, 548217, 548250, 5142242, 5142305, 5142312, 5142315, 514245, 51425212, 51425213, 5142631, 5142661, 514307, 514336, 514340, 514342, 514364, 514367, 514375, 514394, 514406, 514456, 514469, 514415, 514438, 514443
Abstract:

The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

Amidino Compounds As Cysteine Protease Inhibitors
view source
US Patent:

7662849, Feb 16, 2010
Filed:

Jun 4, 2004
Appl. No.:

10/559405
Inventors:

John W. Patterson - Mountain View CA, US
Soon H. Woo - Palo Alto CA, US
Assignee:

ViroBay, Inc. - Menlo Park CA
International Classification:

A61K 31/382
A61K 31/445
C07D 335/02
C07D 211/54
US Classification:

514432, 5142385, 514311, 514331, 514394, 514416, 514451, 514520, 544 59, 544163, 546134, 546230, 546286, 5483044, 548505, 548585, 549 13, 549426, 558392
Abstract:

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

Di-Fluoro Containing Compounds As Cysteine Protease Inhibitors
view source
US Patent:

7781487, Aug 24, 2010
Filed:

Oct 3, 2007
Appl. No.:

11/866836
Inventors:

John O. Link - San Francisco CA, US
Craig J. Mossman - Saratoga CA, US
Jie Liu - Beijing, CN
Soon Hyung Woo - Palo Alto CA, US
Assignee:

ViroBay, Inc. - Menlo Park CA
International Classification:

A61K 31/135
A61P 9/10
A61P 11/06
A61P 17/06
A61P 19/02
C07C 211/02
US Classification:

514646, 564305
Abstract:

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S, and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

Inhibitors Of Histone Deacetylase
view source
US Patent:

7838520, Nov 23, 2010
Filed:

Mar 15, 2005
Appl. No.:

11/081095
Inventors:

Daniel Delorme - St-Lazare, CA
Soon Hyung Woo - Foster City CA, US
Arkadii Vaisburg - Kirkland, CA
Oscar Moradei - Kirkland, CA
Silvana Leit - Kirkland, CA
Stephane Raeppel - Pierrefonds, CA
Sylvie Frechette - Lachine, CA
Giliane Bouchain - Beaconsfield, CA
Zhihong Zhou - Kirkland, CA
Assignee:

MethylGene, Inc. - Montreal
International Classification:

C07D 239/42
C07D 213/02
C07D 209/14
C07D 277/08
C07D 295/02
C07D 401/10
C07D 403/10
C07C 233/07
A61K 31/505
A61K 31/33
A61K 31/186
A61K 31/4164
A61K 31/47
A61P 35/00
US Classification:

5142315, 514617, 514241, 51425201, 5142521, 514256, 514269, 514277, 514359, 544196, 544264, 544283, 544353, 5462681, 564155, 564161
Abstract:

The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

Inhibitors Of Histone Deacetylase
view source
US Patent:

7868204, Jan 11, 2011
Filed:

Mar 25, 2005
Appl. No.:

11/091025
Inventors:

Daniel Delorme - St-Lazare, CA
Soon Hyung Woo - Palo Alto CA, US
Arkadii Vaisburg - Kirkland, CA
Oscar Moradei - Kirkland, CA
Silvana Leit - Kirkland, CA
Stephane Raeppel - Pierrefonds, CA
Sylvie Frechette - Verdun, CA
Giliane Bouchain - Cedar Valley, CA
Assignee:

MethylGene Inc. - Montreal
International Classification:

C07C 211/51
C07C 211/36
C07D 295/02
C07D 263/02
C07D 273/02
C07D 317/06
C07D 317/48
C07D 319/18
A61K 31/136
A61K 31/166
A61K 31/34
A61K 31/357
A61P 35/00
US Classification:

564123, 564155, 564161, 514617, 5142312, 514364, 514374, 514380, 514406, 514438, 514463, 514464, 548131, 548215, 548221, 5483561, 549 68, 549362, 549434, 549478, 549479
Abstract:

The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

Di-Fluoro Containing Compounds As Cysteine Protease Inhibitors
view source
US Patent:

7893112, Feb 22, 2011
Filed:

Apr 1, 2008
Appl. No.:

12/060774
Inventors:

John O. Link - San Francisco CA, US
Craig J. Mossman - Saratoga CA, US
Jie Liu - Shanghai, CN
Soon Hyung Woo - Palo Alto CA, US
Assignee:

Virobay, Inc. - Menlo Park CA
International Classification:

A61K 31/167
A61P 11/00
A61P 19/00
A61P 29/00
US Classification:

514620, 564164
Abstract:

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S, and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

Sulfonamide Compounds As Cysteine Protease Inhibitors
view source
US Patent:

8163735, Apr 24, 2012
Filed:

Dec 1, 2005
Appl. No.:

11/792101
Inventors:

Soon H. Woo - Palo Alto CA, US
Randall W. Vivian - San Mateo CA, US
John O. Link - San Francisco CA, US
Assignee:

Virobay, Inc. - Menlo Park CA
International Classification:

A61K 31/495
A61K 31/55
A61K 31/18
A61K 31/5375
A61K 31/445
A61K 31/44
C07D 265/30
C07D 241/04
C07D 211/08
C07D 223/02
C07D 213/57
C07C 311/01
A61P 9/00
A61P 37/00
A61P 17/06
A61P 29/00
US Classification:

51421712, 5142378, 51425212, 514331, 514357, 514603, 540604, 544159, 544383, 546192, 546330, 564 86
Abstract:

The present invention is directed to compounds of formula (I) that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them. Wherein R3 is -alkylene-SO2NR5R6.